Читать книгу Gas Biology Research in Clinical Practice - Группа авторов - Страница 42

1 Nakao A, Sugimoto R, Billiar TR, et al: Therapeutic antioxidant medical gas. J Clin Biochem Nutr 2009;44:1-13.

2 Motterlini R, Mann BE, Foresti R: Therapeutic applications of carbon monoxide-releasing molecules. Expert Opin Investig Drugs 2005;14:1305-1318.

3 Lundberg JO, Weitzberg E, Gladwin MT: The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nat Rev Drug Discov 2008;7:156-167.

4 Kajiya M, Sato K, Silva MJ, et al: Hydrogen from intestinal bacteria is protective for concanavalin A-induced hepatitis. Biochem Biophys Res Commun 2009;386:316-321.

5 Bathoorn E, Slebos DJ, Postma DS, et al: Anti-inflammatory effects of inhaled carbon monoxide in patients with COPD: a pilot study. Eur Respir J 2007;30:1131-1137.

6 Culotta E, Koshland DE Jr: NO news is good news. Science1992; 258:1862-1865.

7 Creagh-Brown BC, Griffiths MJ, Evans TW: Bench-to-bedside review: Inhaled nitric oxide therapy in adults. Crit Care 2009;13:221.

8 Michael JR, Barton RG, Saffle JR, et al: Inhaled nitric oxide versus conventional therapy: effect on oxygenation in ARDS. Am J Respir Crit Care Med 1998;157:1372-1380.

9 Tenhunen R, Marver HS, Schmid R: The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc Natl Acad Sci USA 1968;61:748-755.

10 Pannen BH, Kohler N, Hole B, et al: Protective role of endogenous carbon monoxide in hepatic microcirculatory dysfunction after hemorrhagic shock in rats. J Clin Invest 1998;102:1220-1228.

11 Nakahira K, Kim HP, Geng XH, et al: Carbon monoxide differentially inhibits TLR signaling pathways by regulating ROS-induced trafficking of TLRs to lipid rafts. J Exp Med 2006;203:2377-2389.

12 Kamoun P: Endogenous production of hydrogen sulfide in mammals. Amino Acids 2004;26:243-254.

13 Leslie M: Medicine. Nothing rotten about hydrogen sulfide’s medical promise. Science 2008;320:1155-1157.

14 Blackstone E, Morrison M, Roth MB: H₂S induces a suspended animation-like state in mice. Science 2005;308:518.

15 Ohsawa I, Ishikawa M, Takahashi K, et al: Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat Med 2007; 13:688-694.

16 Hayashida K, Sano M, Ohsawa I, et al: Inhalation of hydrogen gas reduces infarct size in the rat model of myocardial ischemia-reperfusion injury. Biochem Biophys Res Commun 2008;373:30-35.

17 Ohsawa I, Nishimaki K, Yamagata K, et al: Consumption of hydrogen water prevents athero-sclerosis in apolipoprotein E knockout mice. Biochem Biophys Res Commun 2008;377:1195-1198.

18 Cardinal JS, Zhan J, Wang Y, et al: Oral administration of hydrogen water prevents chronic allograft nephropathy in rat renal transplantation. Kidney Int 2010;77:101-109.

19 Kajiyama S, Hasegawa G, Asano M, et al: Supplementation of hydrogen-rich water improves lipid and glucose metabolism in patients with type 2 diabetes or impaired glucose tolerance. Nutr Res 2008;28:137-143.

20 Cullen SC, Gross EG: The anesthetic properties of xenon in animals and human beings, with additional observations on krypton. Science 1951;113:580-582.

21 Bedi A, Murray JM, Dingley J, et al: Use of xenon as a sedative for patients receiving critical care. Crit Care Med 2003;31:2470-2477.

22 David HN, Haelewyn B, Rouillon C, et al: Neuroprotective effects of xenon: a therapeutic window of opportunity in rats subjected to transient cerebral ischemia. Faseb J 2008;22:1275-1286.

23 Franks JJ, Horn JL, Janicki PK, et al: Halothane, isoflurane, xenon, and nitrous oxide inhibit calcium ATPase pump activity in rat brain synaptic plasma membranes. Anesthesiology 1995;82:108-117.

24 Ma D, Wilhelm S, Maze M, et al: Neuroprotective and neurotoxic properties of the ‘inert’ gas, xenon. Br J Anaesth 2002;89:739-746.

25 Wilhelm S, Ma D, Maze M, et al: Effects of xenon on in vitro and in vivo models of neuronal injury. Anesthesiology 2002;96:1485-1491.

26 Hess DR, Fink JB, Venkataraman ST, et al: The history and physics of heliox. Respir Care 2006;51:608-612.

27 Pan Y, Zhang H, VanDeripe DR, et al: Heliox and oxygen reduce infarct volume in a rat model of focal ischemia. Exp Neurol 2007;205:587-590.

28 Ajamieh H, Merino N, Candelario-Jalil E, et al: Similar protective effect of ischaemic and ozone oxidative preconditioning in liver ischaemia/reperfusion injury. Pharmacol Res 2002;45:333-339.

29 Di Paolo N, Bocci V, Gaggiotti E: Ozone therapy. Int J Artif Organs 2004;27:168-175.

30 Bocci V: Ozone as Janus: this controversial gas can be either toxic or medically useful. Mediators Inflamm 2004;13:3-11.

Dr. Atsunori Nakao

Department of Surgery, University of Pittsburgh Medical Center

Pittsburgh, PA 15213 (USA)

Tel. +1 412 648 9547, Fax +1 412 624 6666, E- Mail anakao@imap.pitt.edu